Multiple U.S. IPOs are scheduled to price in mid-November 2026, including Rezera Inc. on November 12 and vVARDIS Holding AG plus Windward Bio Group AG on November 13, followed by Anthropic’s $61 billion offering on November 19. These reflect an active pipeline supported by recent S-1 and F-1 amendments, with 138 operating-company IPOs priced year-to-date amid normalized post-SpaceX conditions. Healthcare and AI-related issuers dominate recent filings and calendars, while broader equity-market sentiment, Treasury yields, and regulatory timelines influence deal timing. Additional smaller offerings and international listings further increase the likelihood of at least one completion before year-end.